HOME >> MEDICINE >> NEWS
Wavefront LASIK advances refractive surgery

nt wavefront LASIK systems have been approved by the FDA. Alcon's LADARWave Customized Ablation system was approved in October 2002, the VISX Custom Vue system was approved in May of this year and Bausch & Lomb's Zyoptix system recently received preliminary approval by the FDA's Advisory Panel.

Studies comparing results of wavefront LASIK with conventional LASIK found that 90 to 94 percent of patients receiving wavefront LASIK achieved visual acuity of 20/20 or better, whereas up to 80 percent of those receiving conventional LASIK achieved 20/20 or better.

However, wavefront LASIK may not be for everyone. Because wavefront LASIK removes more corneal tissue than conventional LASIK, patients with thin corneas may not be good candidates. Patients with high degrees of aberration, severely dry eyes, or conditions that affect the lens or vitreous fluid inside the eye also may not be good candidates. However, these patients may still be good candidates for conventional LASIK.

Academy spokesperson Daniel Durrie, MD, of Durrie Vision in Overland Park, Kan., said, "It is important that patients get a thorough eye examination by a reputable eye surgeon before undergoing any surgery. They need to understand the potential risks as well as benefits of the procedure."

In addition to refractive surgery, wavefront technology is also being used in the design of contact and intraocular lenses and to diagnose retinal conditions.


'"/>

Contact: Media Relations
media@aao.org
415-561-8534
American Academy of Ophthalmology
2-Oct-2003


Page: 1 2

Related medicine news :

1. Wavefront LASIK demonstrated superior to conventional LASIK
2. Wavefront-guided LASIK improves contrast sensitivity
3. Temperature and humidity can affect LASIK surgery results
4. People with large pupils can now get LASIK and avoid night vision disturbances
5. Having dry eye before LASIK surgery is a risk factor for severe dry eye after surgery
6. Impact of scientific advances on drug studies and membrane research to be explored
7. Ending racial disparities in health care could save 5 times more lives than tech advances
8. Book celebrates centenary of citys advances in public health
9. New scientific advances in gastroenterology
10. Scientists detail latest advances in development of prosthetic devices for paralyzed
11. Latest advances in end-of-life care to be featured at Tampa conference

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Wavefront LASIK advances refractive surgery

(Date:5/29/2015)... Clarkston, Metamora, Michigan (PRWEB) May 29, 2015 ... vulvar region and can cause significant physical, sexual, and ... major life altering disorder of Vulvodynia. The actual diagnosis ... Women’s Excellence in Endometriosis, they realize that this problem ... patient is experiencing any of these symptoms, they need ...
(Date:5/29/2015)... CA (PRWEB) May 29, 2015 For the ... (USAU) to bring the Denver youth ultimate community an opportunity ... learning and individual improvement. The mission of the USAU Nike ... boys and girls to improve, build character, and make lifelong ... for boys and girls of all skill and ability levels, ...
(Date:5/29/2015)... External Counterpulsation, also known as EECP ... patients. The Heart Fit Clinic is the first clinic in ... review from patients who are now completing treatment. , ... treatments of ECP treatment and received great results. His ... does the clinic perform this non-surgical treatment for heart disease, ...
(Date:5/29/2015)... An organizational consultant and part-time college professor, Dr. ... and may be suffering from early dementia. He is ... and in his uncertain relationship with his wife Addie. ... with corporate and government movers and shakers as they ... around him are being diagnosed with Alzheimer’s, Ben wonders ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 Testosterone Centers of ... DFW area, is opening a new center in the Mid-Cities ... rest of the Mid Cities. Located on the south side ... in Hurst, the new testosterone center will open in May ... who suffer from low testosterone. , Like TCT’s other testosterone ...
Breaking Medicine News(10 mins):Health News:US Sports Camps, Nike Sports Camps, and USA Ultimate Host Third Summer of Ultimate Camp in Denver 2Health News:External Counterpulsation at Heart Fit Clinic Receives Raving Review 2Health News:‘Forgetful’ Professor Struggles With Dementia in Compelling New Novel 2Health News:Testosterone Clinics in Colleyville — TCT opens Hurst Location 2Health News:Testosterone Clinics in Colleyville — TCT opens Hurst Location 3
(Date:5/29/2015)... Lilly and Company (NYSE: LLY ) and AstraZeneca ... entered into a clinical trial collaboration to evaluate the ... checkpoint inhibitor, MEDI4736, in combination with CYRAMZA ® ... planned study will assess the combination as a treatment ... Phase I study is expected to establish the safety ...
(Date:5/28/2015)... 2015  Eli Lilly and Company (NYSE: LLY ) ... tender offer for up to $1.6 billion aggregate principal amount ... of notes who tendered, and did not validly withdraw, their ... City time, on May 27, 2015 (the early ... are eligible to receive the total consideration. The total consideration ...
(Date:5/28/2015)... 2015 Research and ... of Jain PharmaBiotech,s new report  "RNAi - ... offering.       (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ... involves the use of double stranded RNA ... is processed into short 21-23 nucleotide RNAs ...
Breaking Medicine Technology:Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 2Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 3Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 4Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 5Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 6Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 7Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 8Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 9Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 10Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 11Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 12Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 13Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 14Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 2Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 3Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 4Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 5Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 2Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 3
Cached News: